RT Journal Article
SR Electronic
T1 Cortical and Subcortical Neuroanatomical Signatures of Schizotypy in 3,004 Individuals Assessed in a Worldwide ENIGMA Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.29.21255609
DO 10.1101/2021.04.29.21255609
A1 Kirschner, Matthias
A1 Hodzic-Santor, Benazir
A1 Antoniades, Mathilde
A1 Nenadic, Igor
A1 Kircher, Tilo
A1 Krug, Axel
A1 Meller, Tina
A1 Grotegerd, Dominik
A1 Fornito, Alex
A1 Arnatkeviciute, Aurina
A1 Bellgrove, Mark A
A1 Tiego, Jeggan
A1 Dannlowski, Udo
A1 Koch, Katharina
A1 Hülsmann, Carina
A1 Kugel, Harald
A1 Enneking, Verena
A1 Klug, Melissa
A1 Leehr, Elisabeth J.
A1 Böhnlein, Joscha
A1 Gruber, Marius
A1 Mehler, David
A1 DeRosse, Pamela
A1 Moyett, Ashley
A1 Baune, Bernhard T.
A1 Green, Melissa
A1 Quidé, Yann
A1 Pantelis, Christos
A1 Chan, Raymond
A1 Wang, Yi
A1 Ettinger, Ulrich
A1 Debbané, Martin
A1 Derome, Melodie
A1 Gaser, Christian
A1 Besteher, Bianca
A1 Diederen, Kelly
A1 Spencer, Tom J
A1 Fletcher, Paul
A1 Rössler, Wulf
A1 Smigielski, Lukasz
A1 Kumari, Veena
A1 Premkumar, Preethi
A1 Park, Haeme R. P.
A1 Wiebels, Kristina
A1 Lemmers-Jansen, Imke
A1 Gilleen, James
A1 Allen, Paul
A1 Kozhuharova, Petya
A1 Marsman, Jan-Bernard
A1 Lebedeva, Irina
A1 Tomyshev, Alexander
A1 Mukhorina, Anna
A1 Kaiser, Stefan
A1 Fett, Anne-Kathrin
A1 Sommer, Iris
A1 Schuite-Koops, Sanne
A1 Paquola, Casey
A1 Larivière, Sara
A1 Bernhardt, Boris
A1 Dagher, Alain
A1 Grant, Phillip
A1 van Erp, Theo G. M.
A1 Turner, Jessica A.
A1 Thompson, Paul M.
A1 Aleman, André
A1 Modinos, Gemma
YR 2021
UL http://medrxiv.org/content/early/2021/04/30/2021.04.29.21255609.abstract
AB Neuroanatomical abnormalities have been reported along a continuum from at-risk stages, including high schizotypy, to early and chronic psychosis. However, a comprehensive neuroanatomical mapping of schizotypy remains to be established. The authors conducted the first large-scale meta-analyses of cortical and subcortical morphometric patterns of schizotypy in healthy individuals, and compared these patterns with neuroanatomical abnormalities observed in major psychiatric disorders. The sample comprised 3,004 unmedicated healthy individuals (12-68 years, 46.5% male) from 29 cohorts of the worldwide ENIGMA Schizotypy working group. Cortical and subcortical effect size maps with schizotypy scores were generated using standardized methods. Pattern similarities were assessed between the schizotypy-related cortical and subcortical maps and effect size maps from comparisons of schizophrenia (SZ), bipolar disorder (BD) and major depression (MDD) patients with controls. Thicker right medial orbitofrontal/ventromedial prefrontal cortex (mOFC/vmPFC) was associated with higher schizotypy scores (r=.07, pFDR=.02). The cortical thickness profile in schizotypy was positively correlated with cortical abnormalities in SZ (r=.33, pspin=.01), but not BD (r=.19, pspin=.16) or MDD (r=-.22, pspin=.10). The schizotypy-related subcortical volume pattern was negatively correlated with subcortical abnormalities in SZ (rho=-.65, pspin=.01), BD (rho=-.63, pspin=.01), and MDD (rho=-.69, pspin=.004). Comprehensive mapping of schizotypy-related brain morphometry in the general population revealed a significant relationship between higher schizotypy and thicker mOFC/vmPFC, in the absence of confounding effects due to antipsychotic medication or disease chronicity. The cortical pattern similarity between schizotypy and schizophrenia yields new insights into a dimensional neurobiological continuity across the extended psychosis phenotype.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCore funding for ENIGMA was provided by the NIH Big Data to Knowledge (BD2K) program under consortium grant U54 EB020403 (PI: Paul M Thompson). GM is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 202397/Z/16/Z). Acknowledgments and funding details for the various participating data contributors are listed in at the end of the Supplement.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Each study sample was collected with participants written informed consent approved by local Institutional Review Boards (IRB). The details of the IRB/oversight body that provided approval or exemption for the research described are given below. Ethical approval was given by the following boards/committees: Institute of Psychiatry Research Ethics Committee at King's College London, Institutional Review Board of University of Muenster, Institutional Review Board of Chinese Academy of Sciences, Institutional Review Board of Monash University Institutional Review Board of Philipps-University Marburg, Institutional Review Board of University of Bonn, Institutional Review Board of University of London, Institutional Review Board of University of Geneva, Institutional Review Board of University of Auckland, Ethics Committee of the Mental Health Research Center, Moscow, Institutional Review Board of McGill University, Institutional Review Board of University of Roehampton, Institutional Review Board of Jena University Hospital, Institutional Review Board of Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell, Institutional Review Board of University of Amsterdam, Ethic Commission Zurich, Institutional Review Board of Brunel University London, Institutional Review Board of University of Groningen, Human Research Ethics Committee at University of Melbourne. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the authors upon request with permission from the chairs and members of the ENIGMA Schizotypy Working Group.